Summary
Results from the NeuroThera® Effectiveness and Safety Trial-2 [NEST-2; NCT00419705] show no difference in efficacy between transcranial laser therapy and sham treatment for the treatment of acute ischemic stroke when applied within 24 hours of diagnosis.
- Ischemia
- Cerebrovascular Disease Clinical Trials
- © 2009 MD Conference Express
Tools
The Results of NEST-2: A Double-Blind, Randomized, Phase III Study Evaluating the Safety and Efficacy of Transcranial Laser Therapy for Acute Ischemic Stroke within 24 Hours of Stroke Onset
Permalink:
Table of contents
Cited By...
- No citing articles found.